The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trial in progress: Sacituzumab govitecan for the treatment of patients with diffuse pleural mesothelioma.
 
Michael Offin
Honoraria - OncLive
Consulting or Advisory Role - American Society for Radiation Oncology; Jazz Pharmaceuticals; Novartis; Pfizer; PharmaMar; Targeted Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
(OPTIONAL) Uncompensated Relationships - Mesothelioma Applied Research Foundation
 
Esther Redin
No Relationships to Disclose
 
Prashasti Agrawal
Honoraria - MJH Life Sciences
 
Parvathy Manoj
No Relationships to Disclose
 
Sarah Ryan
No Relationships to Disclose
 
Khadeja Moses
No Relationships to Disclose
 
Robert Daly
Stock and Other Ownership Interests - CVS Health (I); Lilly (I); Roche/Genentech
Consulting or Advisory Role - Varian Medical Systems
 
Charles Simone
No Relationships to Disclose
 
Jennifer Sauter
Stock and Other Ownership Interests - Chemed; Merck; Pfizer; Thermo Fisher Scientific
Consulting or Advisory Role - Vivace Therapeutics
Travel, Accommodations, Expenses - DAVA Oncology
 
Mara Monetti
No Relationships to Disclose
 
Elizabeth McMahon
No Relationships to Disclose
 
Erica Stumpf
No Relationships to Disclose
 
Clare Wilhelm
Employment - Memorial Sloan-Kettering Cancer Center
 
Michelle Ginsberg
No Relationships to Disclose
 
Valerie Rusch MD
(OPTIONAL) Uncompensated Relationships - Cancer Research UK
 
Alvaro Quintanal-Villalonga
Honoraria - AstraZeneca
Research Funding - Duality Biologics; Foghorn Therapeutics; Jazz Pharmaceuticals
 
Andrea Arfe
No Relationships to Disclose
 
Marjorie Zauderer
Honoraria - Medscape
Consulting or Advisory Role - AstraZeneca/MedImmune; Orion; Roche Molecular Diagnostics
Research Funding - Atara Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Curis (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); Polaris (Inst); Sapience Therapeutics (Inst); Sellas Life Sciences (Inst); Vivace Therapeutics (Inst); Werewolf Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - Mesothelioma Applied Research Foundation
 
Prasad Adusumilli
Consulting or Advisory Role - Atara Biotherapeutics; Bayer; BioArdis; Carisma Therapeutics; ImmPACT-Bio; Imugene; Orion; Outpace Bio
Research Funding - Atara Biotherapeutics
Patents, Royalties, Other Intellectual Property - Atara Biotherapeutics
 
Charles Rudin
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Auron Therapeutics; Daiichi Sankyo/UCB Japan; DISCO; Earli; Genentech/Roche; Jazz Pharmaceuticals; Merck
Research Funding - Daiichi Sankyo (Inst); Merck (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Royalties related to licensing of anti-DLL3 antibodies.